Targeted Lung Cancer Treatment

EGFR (Epidermal growth factor receptor) Inhibitor
        Tyrosine kinase inhibitors (TKI's):

            Erlotinib (Tarceva)
            Gefitinib (Iressa)

        EGFR Monoclonal Antibody:
            Cetuximab (Erbitux)

VEGF (vascular endothelial growth factor) Inhibitor
        Bevacizumab (Avastin)
    
EML4-ALK Inhibitor
        Crizotinib (Xalkori)